Acadian Asset Management
RYTM icon

Acadian Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Acadian Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67K Sell
609
-1,609
-73% -$145K ﹤0.01% 1825
2026
Q1 		$192K Sell
2,218
-3,887
-64% -$378K ﹤0.01% 1601
2025
Q4 		$652K Buy
+6,105
New +$648K ﹤0.01% 1235
2024
Q4 		– Sell
-4,858
Closed -$254K – 2089
2024
Q3 		$254K Buy
+4,858
New +$233K ﹤0.01% 1282

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management's RYTM Position: Q2 2026 in Review

Acadian Asset Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 73% in Q2 2026, selling an estimated $145K and leaving 609 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Acadian Asset Management first reported a position in RYTM in Q3 2024 and has held it in 4 quarters since. The position peaked at $652K in Q4 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Acadian Asset Management held 609 shares of Rhythm Pharmaceuticals worth $67K as of Q2 2026.
  • Acadian Asset Management sold 1,609 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $145K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1825 holding.
  • Acadian Asset Management first reported a position in Rhythm Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • Acadian Asset Management's Rhythm Pharmaceuticals position peaked at $652K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.